Abstract
Presynaptic nerve terminals release neurotransmitters repeatedly, often at high frequency, and in relative isolation from neuronal cell bodies. Repeated release requires cycles of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-complex assembly and disassembly, with continuous generation of reactive SNARE-protein intermediates. Although many forms of neurodegeneration initiate presynaptically, only few pathogenic mechanisms are known, and the functions of presynaptic proteins linked to neurodegeneration, such as α-synuclein, remain unclear. Here, we show that maintenance of continuous presynaptic SNARE-complex assembly required a nonclassical chaperone activity mediated by synucleins. Specifically, α-synuclein directly bound to the SNARE-protein synaptobrevin-2/vesicle-associated membrane protein 2 (VAMP2) and promoted SNARE-complex assembly. Moreover, triple-knockout mice lacking synucleins developed age-dependent neurological impairments, exhibited decreased SNARE-complex assembly, and died prematurely. Thus, synucleins may function to sustain normal SNARE-complex assembly in a presynaptic terminal during aging.
MeSH Terms
Aging
Animals
Cell Line
Cells, Cultured
HSP40 Heat-Shock Proteins/metabolism
Humans
Membrane Fusion
Membrane Proteins/metabolism
Mice
Mice, Knockout
Mice, Transgenic
Nerve Degeneration/metabolism
Neurons/metabolism
Presynaptic Terminals/metabolism
Protein Binding
Rats
Recombinant Fusion Proteins/metabolism
SNARE Proteins/metabolism
Vesicle-Associated Membrane Protein 2/metabolism
alpha-Synuclein/chemistry,genetics,metabolism
Chemicals
HSP40 Heat-Shock Proteins
Membrane Proteins
Recombinant Fusion Proteins
SNARE Proteins
SNCA protein, human
Snca protein, mouse
Vesicle-Associated Membrane Protein 2
alpha-Synuclein
cysteine string protein
vesicle-associated membrane protein 2, mouse
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Burré Jacqueline
Department of Molecular and Cellular Physiology, and Howard Hughes Medical Institute, Stanford University, 1050 Arastradero Road, Palo Alto, CA 94304-5543, USA.
Sharma Manu
Tsetsenis Theodoros
Buchman Vladimir
Etherton Mark R
Südhof Thomas C
References (25)
25 references, click to expand
-
A broken alpha -helix in folded alpha -Synuclein.
J Biol Chem. 2003 Apr 25;278(17):15313-8
PMID: 12586824
-
Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.
Cell. 2005 Nov 4;123(3):383-96
PMID: 16269331
-
A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.
J Biol Chem. 2005 Jun 17;280(24):22670-8
PMID: 15840579
-
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment.
Neurology. 2007 May 1;68(18):1501-8
PMID: 17470753
-
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.
Am J Pathol. 2001 Dec;159(6):2215-25
PMID: 11733371
-
Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology.
Neurobiol Dis. 2009 Jul;35(1):63-74
PMID: 19362593
-
Alpha-synuclein in Lewy bodies.
Nature. 1997 Aug 28;388(6645):839-40
PMID: 9278044
-
Membrane fusion.
Nat Struct Mol Biol. 2008 Jul;15(7):658-64
PMID: 18618939
-
Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.
Neuron. 2010 Jan 14;65(1):66-79
PMID: 20152114
-
Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.
Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14966-71
PMID: 15465911
-
Membrane fusion: grappling with SNARE and SM proteins.
Science. 2009 Jan 23;323(5913):474-7
PMID: 19164740
-
The synaptic vesicle protein CSP alpha prevents presynaptic degeneration.
Neuron. 2004 Apr 22;42(2):237-51
PMID: 15091340
-
Mechanisms of membrane fusion: disparate players and common principles.
Nat Rev Mol Cell Biol. 2008 Jul;9(7):543-56
PMID: 18496517
-
Cysteine string protein-alpha prevents activity-dependent degeneration in GABAergic synapses.
J Neurosci. 2010 May 26;30(21):7377-91
PMID: 20505105
-
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
Science. 1997 Jun 27;276(5321):2045-7
PMID: 9197268
-
Gamma-synuclein and the progression of cancer.
FASEB J. 2007 Nov;21(13):3419-30
PMID: 17567567
-
Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.
J Neurosci. 2007 Feb 7;27(6):1405-10
PMID: 17287515
-
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.
Neuron. 2000 Jan;25(1):239-52
PMID: 10707987
-
Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.
Am J Pathol. 1998 Feb;152(2):367-72
PMID: 9466562
-
Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene.
Mol Cell Biol. 2003 Nov;23(22):8233-45
PMID: 14585981
-
alpha-Synuclein produces a long-lasting increase in neurotransmitter release.
EMBO J. 2004 Nov 10;23(22):4506-16
PMID: 15510220
-
Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
Science. 2002 Feb 1;295(5556):865-8
PMID: 11823645
-
What causes cell death in Parkinson's disease?
Ann Neurol. 2008 Dec;64 Suppl 2:S3-15
PMID: 19127586
-
Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly.
EMBO J. 1994 Nov 1;13(21):5051-61
PMID: 7957071
-
The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.
Trends Neurosci. 1998 Jun;21(6):249-54
PMID: 9641537